185 related articles for article (PubMed ID: 35735183)
1. Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management.
Yousaf A; Sulong S; Abdullah B; Lazim NM
Medeni Med J; 2022 Jun; 37(2):194-202. PubMed ID: 35735183
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
3. Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.
Rito M; Fonseca I
Pathobiology; 2018; 85(1-2):85-95. PubMed ID: 28930752
[TBL] [Abstract][Full Text] [Related]
4. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
5. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.
Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084
[TBL] [Abstract][Full Text] [Related]
6. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
7. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.
Afshari MK; Fehr A; Nevado PT; Andersson MK; Stenman G
Genes Chromosomes Cancer; 2020 Nov; 59(11):652-660. PubMed ID: 32654217
[TBL] [Abstract][Full Text] [Related]
8. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck.
Hunt JL
Arch Pathol Lab Med; 2011 May; 135(5):602-9. PubMed ID: 21526958
[TBL] [Abstract][Full Text] [Related]
9. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
11. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
12. Genomics of mucoepidermoid and adenoid cystic carcinomas.
Yan K; Yesensky J; Hasina R; Agrawal N
Laryngoscope Investig Otolaryngol; 2018 Feb; 3(1):56-61. PubMed ID: 29492469
[TBL] [Abstract][Full Text] [Related]
13. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
Fehr A; Stenman G; Bullerdiek J; Löning T
Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
[TBL] [Abstract][Full Text] [Related]
14. PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms.
Lee JH; Kang HJ; Yoo CW; Park WS; Ryu JS; Jung YS; Choi SW; Park JY; Han N
J Pathol Transl Med; 2019 Jan; 53(1):23-30. PubMed ID: 30424592
[TBL] [Abstract][Full Text] [Related]
15. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
16. [2009 update in salivary gland tumoral pathology].
Uro-Coste E
Ann Pathol; 2009 Sep; 29(4):274-85. PubMed ID: 19900633
[TBL] [Abstract][Full Text] [Related]
17. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
18. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
[TBL] [Abstract][Full Text] [Related]
19. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
20. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]